FGFR Gene Amplification
3 clinical trials · Condition
◉ Watch FGFR Gene Amplification
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer (NCT06995677) | Tyra Biosciences, Inc | 2025-06-27 |
| Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations (NCT06915753) | Tyra Biosciences, Inc | 2025-04-24 |
| BGJ398 in Treating Patients With FGFR Positive Recurrent Head and Neck Cancer (NCT02706691) | University of Chicago | 2018-06-01 |
Track FGFR Gene Amplification automatically
Every clearance here is in the API, with alerts when new ones post.